Isracann Biosciences Inc.
ISCNF · OTC
8/31/2022 | 5/31/2022 | 2/28/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $10 | $10 | $10 | $10 |
| Gross Profit | -$10 | -$10 | -$10 | -$10 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $295 | $645 | $497 | $762 |
| SG&A Expenses | $296 | $527 | $580 | $892 |
| Sales & Mktg Exp. | $0 | -$118 | $83 | $129 |
| Other Operating Expenses | $10 | $10 | $10 | $10 |
| Operating Expenses | $306 | $538 | $590 | $902 |
| Operating Income | -$306 | -$538 | -$590 | -$902 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$10 | -$2,192 | -$30 | $28 |
| Pre-Tax Income | -$316 | -$2,730 | -$620 | -$874 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$316 | -$2,730 | -$620 | -$874 |
| % Margin | – | – | – | – |
| EPS | -0.002 | -0.017 | -0.004 | -0.006 |
| % Growth | 88.4% | -309.5% | 30% | – |
| EPS Diluted | -0.002 | -0.017 | -0.004 | -0.006 |
| Weighted Avg Shares Out | 158,472 | 152,778 | 146,080 | 146,095 |
| Weighted Avg Shares Out Dil | 158,455 | 152,770 | 146,080 | 146,080 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $23 | $23 | $24 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $10 | $10 | $10 | $10 |
| EBITDA | -$306 | -$2,720 | -$610 | -$864 |
| % Margin | – | – | – | – |